Terry Schlotterback - Orthopediatrics Corp Chairman of the Board
| KIDS Stock | USD 32.83 1.02 3.21% |
Chairman
Mr. Terry D. Schlotterback is Independent Chairman of the Board of the Company. He has served as a director since 2009 and as Chairman of the board of directors since September 2013. Mr. Schlotterback was also employed by us from February 2009 to February 2010. Prior to joining our board of directors, Mr. Schlotterback worked for Zimmer from 1982 to 1992 and from 1996 to 2006, where he served in various leadership positions in sales, marketing and research and development, including as President of the Trauma and Spinal divisions. Prior to joining Zimmer, Mr. Schlotterback served in senior management roles for Mitek Surgical Products from 1992 to 1995. Mr. Schlotterback is a founder of the Warsaw, Indiana chapter of VisionTech Angels, an investment group, and TDS Consulting, LLC, which provides consulting services to medical startup companies since 2009.
| Age | 62 |
| Tenure | 15 years |
| Address | 2850 Frontier Drive, Warsaw, IN, United States, 46582 |
| Phone | 574 268 6379 |
| Web | https://www.orthopediatrics.com |
Terry Schlotterback Latest Insider Activity
Tracking and analyzing the buying and selling activities of Terry Schlotterback against Orthopediatrics Corp stock is an integral part of due diligence when investing in Orthopediatrics Corp. Terry Schlotterback insider activity provides valuable insight into whether Orthopediatrics Corp is net buyers or sellers over its current business cycle. Note, Orthopediatrics Corp insiders must abide by specific rules, including filing SEC forms every time they buy or sell Orthopediatrics Corp'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Terry Schlotterback over six months ago Orthopediatrics Corp exotic insider transaction detected | ||
Terry Schlotterback over six months ago Sale by Terry Schlotterback of 2610 shares of Orthopediatrics Corp | ||
Terry Schlotterback over six months ago Exercise or conversion by Terry Schlotterback of 670 shares of Orthopediatrics Corp subject to Rule 16b-3 | ||
Terry Schlotterback over a year ago Orthopediatrics Corp exotic insider transaction detected |
Orthopediatrics Corp Management Efficiency
The company has return on total asset (ROA) of (0.0372) % which means that it has lost $0.0372 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0555) %, meaning that it created substantial loss on money invested by shareholders. Orthopediatrics Corp's management efficiency ratios could be used to measure how well Orthopediatrics Corp manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.08 in 2024. Return On Capital Employed is likely to drop to -0.07 in 2024. At this time, Orthopediatrics Corp's Total Assets are comparatively stable compared to the past year. Net Tangible Assets is likely to gain to about 255.9 M in 2024, whereas Total Current Assets are likely to drop slightly above 122.2 M in 2024.Similar Executives
| Showing other executives | CHAIRMAN Age | ||
| Stephen Craney | Electromed | 73 | |
| William Link | Glaukos Corp | 74 | |
| Laing Rikkers | ProSomnus Common Stock | N/A | |
| William Kozy | LivaNova PLC | 72 | |
| Thomas Burns | Glaukos Corp | 63 | |
| Aleksandr Dyukov | Si Bone | 50 | |
| George Winn | Electromed | 80 | |
| Anatoly Cherner | Si Bone | 63 | |
| Ronald Matricaria | Orthofix Medical | 74 | |
| Aleksey Miller | Si Bone | 56 | |
| Mark Tryniski | CONMED | 60 | |
| Curt Hartman | CONMED | 60 | |
| Abhijit Talwalkar | iRhythm Technologies | 54 | |
| Vadim Yakovlev | Si Bone | 47 | |
| Daniel Moore | LivaNova PLC | 57 | |
Management Performance
| Return On Equity | -0.0555 | ||||
| Return On Asset | -0.0372 |
Orthopediatrics Corp Leadership Team
Elected by the shareholders, the Orthopediatrics Corp's board of directors comprises two types of representatives: Orthopediatrics Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Orthopediatrics. The board's role is to monitor Orthopediatrics Corp's management team and ensure that shareholders' interests are well served. Orthopediatrics Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Orthopediatrics Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Pelizzon, Independent Director | ||
| Marie Infante, Independent Director | ||
| Samuel Riccitelli, Independent Director | ||
| Bryan Hughes, Independent Director | ||
| Joel Batts, Senior Affairs | ||
| David Bailey, Executive Vice President | ||
| Mark Throdahl, President CEO, Director | ||
| Alan Kozlowski, Independent Director | ||
| Joseph Hauser, President Correction | ||
| Gregory Odle, Executive Vice President | ||
| Mark Karshner, Senior Sales | ||
| Peter Armstrong, Chief Medical Officer | ||
| Terry Schlotterback, Chairman of the Board | ||
| Bernie Berry, Independent Director | ||
| Stephen Burns, Independent Director | ||
| MBAMSHA CHE, President Technologies | ||
| Daniel Gerritzen, General Counsel and Vice President of Legal and Human Resources | ||
| Kevin Unger, Independent Director | ||
| Harald Ruf, Director | ||
| Fred Hite, CFO, Director | ||
| Peter Munson, Independent Director | ||
| Oscar Moralez, Independent Director | ||
| Tram Bui, IR Contact Officer |
Orthopediatrics Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Orthopediatrics Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0555 | ||||
| Return On Asset | -0.0372 | ||||
| Profit Margin | (0.14) % | ||||
| Operating Margin | (0.21) % | ||||
| Current Valuation | 661.73 M | ||||
| Shares Outstanding | 23.79 M | ||||
| Shares Owned By Insiders | 31.89 % | ||||
| Shares Owned By Institutions | 71.58 % | ||||
| Number Of Shares Shorted | 982.73 K | ||||
| Price To Earning | (10.06) X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Orthopediatrics Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For more information on how to buy Orthopediatrics Stock please use our How to Invest in Orthopediatrics Corp guide.Note that the Orthopediatrics Corp information on this page should be used as a complementary analysis to other Orthopediatrics Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Complementary Tools for Orthopediatrics Stock analysis
When running Orthopediatrics Corp's price analysis, check to measure Orthopediatrics Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthopediatrics Corp is operating at the current time. Most of Orthopediatrics Corp's value examination focuses on studying past and present price action to predict the probability of Orthopediatrics Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthopediatrics Corp's price. Additionally, you may evaluate how the addition of Orthopediatrics Corp to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |
Is Orthopediatrics Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Orthopediatrics Corp. If investors know Orthopediatrics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Orthopediatrics Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.92) | Revenue Per Share 6.559 | Quarterly Revenue Growth 0.214 | Return On Assets (0.04) | Return On Equity (0.06) |
The market value of Orthopediatrics Corp is measured differently than its book value, which is the value of Orthopediatrics that is recorded on the company's balance sheet. Investors also form their own opinion of Orthopediatrics Corp's value that differs from its market value or its book value, called intrinsic value, which is Orthopediatrics Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Orthopediatrics Corp's market value can be influenced by many factors that don't directly affect Orthopediatrics Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Orthopediatrics Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Orthopediatrics Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Orthopediatrics Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.